GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Astec Lifesciences Ltd (BOM:533138) » Definitions » Cash Conversion Cycle

Astec Lifesciences (BOM:533138) Cash Conversion Cycle : 202.52 (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Astec Lifesciences Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Astec Lifesciences's Days Sales Outstanding for the three months ended in Mar. 2025 was 112.56.
Astec Lifesciences's Days Inventory for the three months ended in Mar. 2025 was 183.86.
Astec Lifesciences's Days Payable for the three months ended in Mar. 2025 was 93.9.
Therefore, Astec Lifesciences's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2025 was 202.52.


Astec Lifesciences Cash Conversion Cycle Historical Data

The historical data trend for Astec Lifesciences's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astec Lifesciences Cash Conversion Cycle Chart

Astec Lifesciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.84 112.63 176.16 255.59 262.85

Astec Lifesciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 189.22 341.48 199.36 229.19 202.52

Competitive Comparison of Astec Lifesciences's Cash Conversion Cycle

For the Agricultural Inputs subindustry, Astec Lifesciences's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astec Lifesciences's Cash Conversion Cycle Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Astec Lifesciences's Cash Conversion Cycle falls into.


;
;

Astec Lifesciences Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Astec Lifesciences's Cash Conversion Cycle for the fiscal year that ended in Mar. 2025 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=151.46+214.42-103.03
=262.85

Astec Lifesciences's Cash Conversion Cycle for the quarter that ended in Mar. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=112.56+183.86-93.9
=202.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Astec Lifesciences  (BOM:533138) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Astec Lifesciences Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Astec Lifesciences's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Astec Lifesciences Business Description

Traded in Other Exchanges
Address
Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.

Astec Lifesciences Headlines

No Headlines